These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 10393287)
1. Effect of dead volume on the efficiency and the cost to deliver medications in cystic fibrosis with four disposable nebulizers. Ho SL; Coates AL Can Respir J; 1999; 6(3):253-60. PubMed ID: 10393287 [TBL] [Abstract][Full Text] [Related]
2. The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols. Coates AL; MacNeish CF; Meisner D; Kelemen S; Thibert R; MacDonald J; Vadas E Chest; 1997 May; 111(5):1206-12. PubMed ID: 9149571 [TBL] [Abstract][Full Text] [Related]
3. Effect of nebulizer type and antibiotic concentration on device performance. Weber A; Morlin G; Cohen M; Williams-Warren J; Ramsey B; Smith A Pediatr Pulmonol; 1997 Apr; 23(4):249-60. PubMed ID: 9141110 [TBL] [Abstract][Full Text] [Related]
4. Nebulizer choice for inhaled colistin treatment in cystic fibrosis. Katz SL; Ho SL; Coates AL Chest; 2001 Jan; 119(1):250-5. PubMed ID: 11157612 [TBL] [Abstract][Full Text] [Related]
5. Measuring nebulizer output. Aerosol production vs gravimetric analysis. Tandon R; McPeck M; Smaldone GC Chest; 1997 May; 111(5):1361-5. PubMed ID: 9149595 [TBL] [Abstract][Full Text] [Related]
6. A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers. Coates AL; MacNeish CF; Lands LC; Meisner D; Kelemen S; Vadas EB Chest; 1998 Apr; 113(4):951-6. PubMed ID: 9554630 [TBL] [Abstract][Full Text] [Related]
7. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer. Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW Int J Pharm; 1999 Nov; 189(2):205-14. PubMed ID: 10536249 [TBL] [Abstract][Full Text] [Related]
8. Comparison of drug delivery from conventional versus "Venturi" nebulizers. Devadason SG; Everard ML; Linto JM; Le Souëf PN Eur Respir J; 1997 Nov; 10(11):2479-83. PubMed ID: 9426082 [TBL] [Abstract][Full Text] [Related]
9. Characterization of aerosol output from various nebulizer/compressor combinations. Reisner C; Katial RK; Bartelson BB; Buchmeir A; Rosenwasser LJ; Nelson HS Ann Allergy Asthma Immunol; 2001 May; 86(5):566-74. PubMed ID: 11379809 [TBL] [Abstract][Full Text] [Related]
10. Effects of repetitive use and cleaning techniques of disposable jet nebulizers on aerosol generation. Standaert TA; Morlin GL; Williams-Warren J; Joy P; Pepe MS; Weber A; Ramsey BW Chest; 1998 Aug; 114(2):577-86. PubMed ID: 9726748 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal evaluation of compressor/nebulizer performance. Awad S; Williams DK; Berlinski A Respir Care; 2014 Jul; 59(7):1053-61. PubMed ID: 24149670 [TBL] [Abstract][Full Text] [Related]
13. Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizer. Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW Int J Pharm; 1999 Nov; 189(2):215-25. PubMed ID: 10536250 [TBL] [Abstract][Full Text] [Related]
14. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model. Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995 [TBL] [Abstract][Full Text] [Related]
15. Effect of nebulizer type, delivery interface, and flow rate on aerosol drug delivery to spontaneously breathing pediatric and infant lung models. Ari A Pediatr Pulmonol; 2019 Nov; 54(11):1735-1741. PubMed ID: 31313534 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover study. van Velzen AJ; Uges JWF; Heijerman HGM; Arets BGM; Nuijsink M; van der Wiel-Kooij EC; van Maarseveen EM; van Zanten GA; Pullens B; Touw DJ; Janssens HM Br J Clin Pharmacol; 2019 Sep; 85(9):1984-1993. PubMed ID: 31112621 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of four breath-enhanced nebulizers for home use. Ho SL; Kwong WT; O'Drowsky L; Coates AL J Aerosol Med; 2001; 14(4):467-75. PubMed ID: 11791687 [TBL] [Abstract][Full Text] [Related]
18. In vitro aerodynamic characterization of the dose emitted during nebulization of tobramycin high strength solution by novel and jet nebulizer delivery systems. Mashat M; Clark BJ; Assi KH; Chrystyn H Pulm Pharmacol Ther; 2016 Apr; 37():37-42. PubMed ID: 26747025 [TBL] [Abstract][Full Text] [Related]
19. Nebulizer performance: AFLM study. Association Française de Lutte contre la Mucoviscidose. Faurisson F; Dessanges JF; Grimfeld A; Beaulieu R; Kitzis MD; Peytavin G; Lefebvre JP; Farinotti R; Sautegeau A Respiration; 1995; 62 Suppl 1():13-8. PubMed ID: 7792434 [TBL] [Abstract][Full Text] [Related]
20. Comparison of two methods of delivering continuously nebulized albuterol. Kelly HW; Keim KA; McWilliams BC Ann Pharmacother; 2003 Jan; 37(1):23-6. PubMed ID: 12503928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]